Wednesday, 18 September 2019

Servier Australia, BioCurate to accelerate drug discovery

17 July 2019 | News

To collaborate and accelerate discoveries of new therapeutics and drugs

image credit- shuttershock.com

image credit- shuttershock.com

Servier Australia and BioCurate have struck an agreement to share commercial and scientific expertise with the aim of accelerating the discovery of new therapeutics and drugs.

Servier and BioCurate will collaborate under the terms of a memorandum of understanding (MOU), whereby they will work together, both directly and via participation in BioCurate’s Industry and Scientific Advisory Committee, in providing advice and assessing new therapeutic candidates arising from BioCurate’s academic partners.

The signing of this MOU provides further endorsement from industry of BioCurate’s collaborative approach and its capability in improving the quality of early stage research for a successful translation into therapeutic solutions for the benefit of patients.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls